Navigation Links
Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation

Goal to Distinguish Science Questions from Policy Debates

Agencies Should Empanel Scientific Advisory Committees Solely of Members with Relevant Scientific Expertise; Improve Disclosure and Transparency

WASHINGTON, Aug. 5 /PRNewswire-USNewswire/ -- A bipartisan panel of top scientific and regulatory experts today released recommendations calling on the White House and federal agencies to make specific changes in the regulatory process to clearly distinguish scientific questions from policy disputes. The report comes from the Science for Policy Project (SPP). A project of the Bipartisan Policy Center, SPP is co-chaired by former Rep. Sherwood Boehlert (R-NY), past chair of the House Science Committee, and Donald Kennedy, former editor of Science; and eleven other ideologically diverse members from business, academia, government and non-profits. The complete list of panel members appears below.

"The fundamental theme of the report is that the Administration needs to put in place procedures to try to distinguish science questions from policy questions," said Boehlert. "Often, policy disputes are cast as fights over science. This damages the credibility of science and obscures the real issues that ought to be debated. For example, how much risk a substance poses to human health or the environment is a science question; how much risk is acceptable is a policy question."

"Our recommendations would make the regulatory process more rigorous and transparent," said Kennedy, who headed the Food and Drug Administration (FDA) under President Jimmy Carter. "That should lead to better, more thoughtful regulations and greater consensus when the government is considering whether or not to regulate. And perhaps most important, when there are disagreements, officials and the public will have a clearer sense of what they are about."

The report recommends requiring new information when regulations are proposed by agencies such as the Environmental Protection Agency and the FDA, and enhancing the credibility of federal advisory committees to ensure the integrity of science in regulatory policymaking. Many of these recommendations are relevant to the White House and federal agency effort to implement President Obama's March 9, 2009 Presidential Memorandum on Scientific Integrity. An interim version of the SPP report was released in March, and the White House has reviewed that report as part of its work to issue guidelines on scientific integrity and regulatory reform, which are expected soon.

The report's recommendations include:

  • Clarity regarding key science questions needed to write specific regulations. Federal Register notices for proposed regulations should make clear what science questions and what policy questions needed to be answered to formulate the regulation and what science was most influential in drafting the regulation. The notices might also make clear what additional science would help resolve remaining questions and might offer policy alternatives that are consistent with the science.
  • Greater focus on science in advisory committees. Federal agencies should empanel scientific advisory committees - committees that are composed solely of members with relevant scientific expertise - to address science questions relevant to policy, and those panels should not make policy recommendations. Members of such committees should be Special Government Employees, a category that makes them subject to conflict of interest and other ethics rules.
  • Greater transparency in committee appointment process. The process for appointing committees should be more transparent, with agencies taking steps including seeking names through the Web and asking for comments on proposed individuals on the Web.
  • More disclosure by committee members. Members of scientific advisory committees should be required to disclose to the government and to the public far more information on their backgrounds than is currently the case so the government and the public can evaluate their qualifications and determine whether their service raises any concern about conflicts of interest or bias.
  • Clearer conflict of interest rules. The government should set clear rules about what constitutes a conflict of interest for a member of a scientific advisory committee. The government should distinguish clearly between conflict of interest and bias. Agencies should try not to appoint advisory committee members with conflicts of interest, but if such individuals are appointed, the appointment should be publicly announced and justified. The standard for appointing members with conflicts should be changed to the one used by the National Academy of Sciences. Chairs or co-chairs of committees should never have conflicts.
  • Greater transparency in committee selection might allow a limited number of closed committee meetings. If procedures are put in place to make the selection of advisory committee members more transparent, then the government could consider allowing scientific advisory committees to have a limited number of closed meetings under specific circumstances.
  • Transparency in the use of scientific literature. The process agencies and scientific advisory committees use to review the scientific literature should become more transparent and thorough. They should be explicit about the criteria they are using to determine which scientific papers to review and how those papers are being evaluated, and should pay more attention to the methodology used in cited work. In general, papers that have not been peer reviewed should be treated with skepticism, but they should not be automatically excluded.
  • Legitimate use of Confidential Business Information. The Confidential Business Information designation, which limits public access to information, is legitimate but appears to be overused. Agencies should consider ways to ensure that the category is being used legitimately, such as requiring businesses to provide a brief but substantive justification for requesting protection.
  • Greater participation in, and improved quality of peer review. Federal agencies, universities and scientific journals need to experiment with ways to encourage more scientists to act as peer reviewers and to experiment with different peer review procedures to see what will improve the quality of reviews.

The report makes detailed recommendations about the formation and use of scientific advisory committees, including setting requirements for disclosure and determining and dealing with conflicts of interest and bias.

The study also focuses on the evaluation of research studies by agencies and scientific advisory committees, and criteria such as peer review, conflicts of interest, sponsor control of research and publication, data availability, and risk and uncertainty.

"The overall purpose of our report," said Kennedy, "is to inaugurate an era in which the science behind regulatory proposals will emerge from a more transparent and credible process. Disagreements over political ideology, economics and values that are at the heart of many regulatory disputes will be debated more openly and fully if these reforms are implemented. Science will be better protected from unwarranted attacks and political values will be more fully debated. Better regulatory policy will protect the public from both needless regulations and from needless dangers."

Boehlert added, "The very fact that this ideologically diverse group was able to reach consensus on specific recommendations for reform shows that the time is ripe for these changes."

The Science for Policy Project is funded by the David and Lucile Packard Foundation, the William and Flora Hewlett Foundation, and ExxonMobil Foundation. The project was directed by David Goldston, the former chief of staff of the House Science Committee. Copies of the full report are available at

Members of the Bipartisan Policy Center's Science for Policy Project:*

HON. SHERWOOD BOEHLERT (co-chair): The Accord Group

DONALD KENNEDY (co-chair): Stanford University

ARTHUR CAPLAN: University of Pennsylvania

LINDA J. FISHER: E. I. du Pont de Nemours and Company

LYNN R. GOLDMAN: Johns Hopkins University

JOHN D. GRAHAM: Indiana University

DANIEL GREENBAUM: Health Effects Institute

MICHAEL P. HOLSAPPLE: ILSI Health and Environmental Sciences Institute

KEVIN KNOBLOCH: Union of Concerned Scientists

KENNETH OLDEN: City University of New York

ROGER A. PIELKE, JR.: University of Colorado

SHERRI K. STUEWER: Exxon Mobil Corporation

WENDY E. WAGNER: University of Texas

*panelist affiliations listed for identification purposes only.

About the Bipartisan Policy Center:

In 2007, former U.S. Senate Majority Leaders Howard Baker, Tom Daschle, Bob Dole, and George Mitchell formed the Bipartisan Policy Center(BPC) to develop and promote solutions that can attract the public support and political momentum to achieve real progress. The BPC acts as an incubator for policy efforts that engage top political figures, advocates, academics, and business leaders in the art of principled compromise. For more information, please visit our website:

    Contact: Paul Bledsoe, (202) 204-2403
    Additional Contact: Eileen McMenamin, (202) 379-1633

SOURCE Bipartisan Policy Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. In Case You Missed It: The Washington Posts Ruth Marcus: A Bipartisan Plan on Health Care? Try Two
2. National Coalition of Front-Line Skilled Nursing Clinicians: Bipartisan Momentum to Stop CMS Medicare Regulation, Subsequent Funding Cuts, Grows in Congress
3. Health Plans Return to Airwaves in Support of Bipartisan Reform
4. Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care Nationwide
5. Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform
6. National Restaurant Association Backs Bipartisan Senate Agreement to Empower Consumers Nationwide With More Nutrition Information
7. Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform
8. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Indiana and Nationally
9. Americans United for Life Represents 28 Bipartisan Montana Legislators Arguing Assisted Suicide Not a Right
10. San Francisco Bay Area Affiliate of Susan G. Komen for the Cure(R) Applauds Introduction of Bipartisan Cancer Alert Act
11. National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease
Post Your Comments:
(Date:3/23/2017)... ... , ... A recent report from the National Council on Teacher Quality (NCTQ) ... suggests, based on a review of GPA and SAT/ACT requirements at 221 institutions in ... It argues that this higher bar should be set by states, by the Council ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Convention Center at 10 North Broadway Avenue, will be an educational and exciting ... practical instruction in the management of chronic pain. , Oklahoma is in a ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... firm serving the families and businesses of the Norwalk and Vermillion areas, ... Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... funding investment in Los Angeles based healthcare technology company California Healthcom Group (CHG). ... into the US, and healthcare arena. With headquarters in California, CHG is a ...
(Date:3/23/2017)... ... , ... March 23, 2017 - Crawford Technologies announced today ... invoices, bills, statements and other correspondence when they have been lost or destroyed. ... print the documents and batch them for efficient handling. , Many organizations ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: ... integrated commercial company that provides clinically useful molecular ... it has entered into agreements to successfully restructure ... ("RedPath") and concurrently terminate its royalty and milestone ... debt to RedPath amounting to $9.34 million is ...
(Date:3/23/2017)... , March 23, 2017 A research ... market is expected to reach USD 7.2 billion by the ... Sample preparation is a procedure in which a sample is ... in most analytical procedures since the methods are often allowing ... one of the most shared procedures in the lab. In ...
(Date:3/23/2017)... CENTRO DE IMAGEM DIAGNOSTICOS S.A. (" Company ... Law 6,404/76 and Instruction 358/02 of the Brazilian Securities ... the market in general that it entered yesterday, as ... por Imagem Ltda. (" CDI "), into an agreement ... LTDA. (" Partnership " and " Acquisition "). ...
Breaking Medicine Technology: